We developed a direct injection-based LC–MS/MS method to obtain teicoplanin in human plasma.
Only 20 μL of plasma was required for sample preparation.
Patient plasma samples were diluted in an aqueous buffer prior to injection into the LC–MS/MS system.
The method was fully validated and successfully applied to therapeutic drug monitoring (TDM) of teicoplanin in routine clinical practice.